Hans Jørgen Aarstad1,2, Arild Andrè Østhus3, Helene Hersvik Aarstad4, Stein Lybak4,3, Anne Kari Hersvik Aarstad4,5. 1. Department of Clinical Medicine, Faculty of Medicine, University of Bergen, Bergen, Norway. hans.aarstad@ore.uib.no. 2. Department of Otolaryngology/Head and Neck Surgery, Haukeland University Hospital, 5020, Bergen, Norway. hans.aarstad@ore.uib.no. 3. Department of Otolaryngology/Head and Neck Surgery, Haukeland University Hospital, 5020, Bergen, Norway. 4. Department of Clinical Medicine, Faculty of Medicine, University of Bergen, Bergen, Norway. 5. Faculty of Health Sciences, University of Stavanger, Stavanger, Norway.
Abstract
OBJECTIVES: To evaluate the 5- and 10-year survival prediction of health-related quality of life (HRQoL) scores obtained at diagnosis and at 6, 9 and 12 months after diagnosis in a cohort of curable head and neck squamous cell carcinoma (HNSCC) patients. MATERIALS AND METHODS: HNSCC patients (n = 109) reported their HRQoL measured by the EORTC Quality of Life Questionnaire (QLQ) general (C30) questionnaire. At diagnosis, the included patients were below 78 years of age and at diagnosis planned treated with curative intent. Clinical variables and self-reported smoking, alcohol consumption and socio-demographic information were registered. From diagnostic blocks, we found 22 patients to be human papillomavirus (HPV) positive. New HRQoL scores were not obtained if the patient treatment changed from curative to palliative throughout the HRQoL data acquisition. Survival was determined from the National Population Register of Norway. RESULTS: Decreased survival with low HRQoL scores from EORTC QLQ scores was demonstrated with HRQoL scores obtained from different time points of the four time points studied. These survival predictions were mostly independent of HPV status, gender, age, TNM stage, tumor site, alcohol consumption, present smoking status and whether comorbidities were present at diagnosis; as well as to some extent with an adjustment of the same HRQoL score/index obtained at diagnosis. The specific indices "physical function", "general pain" and "sleep disturbance" were in particular predictive of survival. CONCLUSION: HRQoL scores obtained throughout the first year after diagnosis contained prognostic power to overall survival when measured both at 5 and 10 years of observation.
OBJECTIVES: To evaluate the 5- and 10-year survival prediction of health-related quality of life (HRQoL) scores obtained at diagnosis and at 6, 9 and 12 months after diagnosis in a cohort of curable head and neck squamous cell carcinoma (HNSCC) patients. MATERIALS AND METHODS:HNSCCpatients (n = 109) reported their HRQoL measured by the EORTC Quality of Life Questionnaire (QLQ) general (C30) questionnaire. At diagnosis, the included patients were below 78 years of age and at diagnosis planned treated with curative intent. Clinical variables and self-reported smoking, alcohol consumption and socio-demographic information were registered. From diagnostic blocks, we found 22 patients to be human papillomavirus (HPV) positive. New HRQoL scores were not obtained if the patient treatment changed from curative to palliative throughout the HRQoL data acquisition. Survival was determined from the National Population Register of Norway. RESULTS: Decreased survival with low HRQoL scores from EORTC QLQ scores was demonstrated with HRQoL scores obtained from different time points of the four time points studied. These survival predictions were mostly independent of HPV status, gender, age, TNM stage, tumor site, alcohol consumption, present smoking status and whether comorbidities were present at diagnosis; as well as to some extent with an adjustment of the same HRQoL score/index obtained at diagnosis. The specific indices "physical function", "general pain" and "sleep disturbance" were in particular predictive of survival. CONCLUSION: HRQoL scores obtained throughout the first year after diagnosis contained prognostic power to overall survival when measured both at 5 and 10 years of observation.
Entities:
Keywords:
HPV; Head and neck; Neoplasms; Prognosis; Quality of life
Authors: Chantal Quinten; Francesca Martinelli; Corneel Coens; Mirjam A G Sprangers; Jolie Ringash; Carolyn Gotay; Kristin Bjordal; Eva Greimel; Bryce B Reeve; John Maringwa; Divine E Ediebah; Efstathios Zikos; Madeleine T King; David Osoba; Martin J Taphoorn; Henning Flechtner; Joseph Schmucker-Von Koch; Joachim Weis; Andrew Bottomley Journal: Cancer Date: 2013-10-11 Impact factor: 6.860
Authors: Annette J van Nieuwenhuizen; Laurien M Buffart; Johannes Brug; C René Leemans; Irma M Verdonck-de Leeuw Journal: Oral Oncol Date: 2014-09-26 Impact factor: 5.337
Authors: Irma M Verdonck-de Leeuw; Annette van Nieuwenhuizen; C René Leemans Journal: Curr Opin Otolaryngol Head Neck Surg Date: 2012-04 Impact factor: 2.064
Authors: Akinyemi I Ojesina; Lee Lichtenstein; Samuel S Freeman; Chandra Sekhar Pedamallu; Ivan Imaz-Rosshandler; Trevor J Pugh; Andrew D Cherniack; Lauren Ambrogio; Kristian Cibulskis; Bjørn Bertelsen; Sandra Romero-Cordoba; Victor Treviño; Karla Vazquez-Santillan; Alberto Salido Guadarrama; Alexi A Wright; Mara W Rosenberg; Fujiko Duke; Bethany Kaplan; Rui Wang; Elizabeth Nickerson; Heather M Walline; Michael S Lawrence; Chip Stewart; Scott L Carter; Aaron McKenna; Iram P Rodriguez-Sanchez; Magali Espinosa-Castilla; Kathrine Woie; Line Bjorge; Elisabeth Wik; Mari K Halle; Erling A Hoivik; Camilla Krakstad; Nayeli Belem Gabiño; Gabriela Sofia Gómez-Macías; Lezmes D Valdez-Chapa; María Lourdes Garza-Rodríguez; German Maytorena; Jorge Vazquez; Carlos Rodea; Adrian Cravioto; Maria L Cortes; Heidi Greulich; Christopher P Crum; Donna S Neuberg; Alfredo Hidalgo-Miranda; Claudia Rangel Escareno; Lars A Akslen; Thomas E Carey; Olav K Vintermyr; Stacey B Gabriel; Hugo A Barrera-Saldaña; Jorge Melendez-Zajgla; Gad Getz; Helga B Salvesen; Matthew Meyerson Journal: Nature Date: 2013-12-25 Impact factor: 49.962
Authors: Hans Jørgen Aarstad; Olav K Vintermyr; Elling Ulvestad; Helene H Aarstad; Kenneth W Kross; John H Heimdal Journal: APMIS Date: 2015-04 Impact factor: 3.205
Authors: Efstathios Zikos; Corneel Coens; Chantal Quinten; Divine E Ediebah; Francesca Martinelli; Irina Ghislain; Madeleine T King; Carolyn Gotay; Jolie Ringash; Galina Velikova; Bryce B Reeve; Eva Greimel; Charles S Cleeland; Henning Flechtner; Martin J B Taphoorn; Joachim Weis; Joseph Schmucker-von Koch; Mirjam A G Sprangers; Andrew Bottomley Journal: J Natl Cancer Inst Date: 2015-12-28 Impact factor: 13.506
Authors: Hans Jørgen Aarstad; Arild Andrè Østhus; Helene Hersvik Aarstad; Stein Lybak; Anne Kari H Aarstad Journal: Eur Arch Otorhinolaryngol Date: 2019-09-16 Impact factor: 2.503
Authors: Sagar Kansara; Tao Wang; Sina Koochakzadeh; Nelson E Liou; Evan M Graboyes; Judith M Skoner; Joshua D Hornig; Vlad C Sandulache; Terry A Day; Andrew T Huang Journal: Oral Oncol Date: 2019-09-12 Impact factor: 5.337
Authors: Janet H Van Cleave; Mei R Fu; Antonia V Bennett; Catherine Concert; Ann Riccobene; Anh Tran; Allison Most; Maria Kamberi; Jacqueline Mojica; Justin Savitski; Elise Kusche; Mark S Persky; Zujun Li; Adam S Jacobson; Kenneth S Hu; Michael J Persky; Eva Liang; Patricia M Corby; Brian L Egleston Journal: Mhealth Date: 2021-01-20
Authors: A J van Nieuwenhuizen; L M Buffart; J A Langendijk; M R Vergeer; J Voortman; C R Leemans; I M Verdonck-de Leeuw Journal: Qual Life Res Date: 2020-12-08 Impact factor: 4.147
Authors: S N Rogers; A E Waylen; S Thomas; C Penfold; M Pring; T Waterboer; M Pawlita; K Hurley; A R Ness Journal: Eur Arch Otorhinolaryngol Date: 2020-02-15 Impact factor: 2.503